KATY round-table discussion in Lisbon | 13 March 2025
We are pleased to share that our partner, The Department of Innovation and Digitalisation in Law (University of Vienna), took part in the roundtable discussionย hosted by the KATY project, an EU-funded initiative.
On the 13th of March 2025, Department of Innovation and Digitalisation in Law (University of Vienna) conducted a round-table talk titled ๐๐ ๐๐ฐ๐ ๐๐บ๐ฝ๐น๐ฒ๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป ๐ถ๐ป ๐๐ต๐ฒ ๐๐ฒ๐ฎ๐น๐๐ต ๐ฆ๐ฒ๐ฐ๐๐ผ๐ฟ – ๐๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ข๐ฝ๐ฝ๐ผ๐ฟ๐๐๐ป๐ถ๐๐ถ๐ฒ๐ on the legal, ethical, and societal aspects of the AI technologies in medical sector, and the impact, reception and regulatory aspects of the recently enacted EU AI Act (2024).
The discussion was part of the ๐๐๐ง๐ฌ Annual Progress Meeting which took place in Lisbon.
This event brought together researchers, policymakers, and industry experts to explore the challenges and opportunities that the AI Act presents for AI-driven healthcare solutions. Events like this provide an excellent platform to engage with stakeholders and address critical regulatory challenges in health tech innovation.
The roundtable was attended by a panel of excellent external experts from law, human rights, AI, and healthcare, who are involved in medical research projects similar to KATY:
โพ๏ธ Dr. Alexander Kriebitz, who represented MELISSAdiabetes project,
โพ๏ธ Priv.-Doz. Dr. med. Keno Bressem and Dr. Felix Busch, presenting COMFORT-EU project,
โพ๏ธ Univ.-Prof. Dr. med. Petra Ritter, who represented ๐ง๐๐-๐๐ฒ๐ฎ๐น๐๐ต project,
โพ๏ธ Dr. David M. Schneeberger, representing dAIbetes_EU,
โพ๏ธ Alexandra Mวrginean, who spoke on behalf of ๐ฃ๐ต๐ฎ๐๐ฒ ๐๐ฉ ๐๐,
โพ๏ธ Olga Startseva, who represented ๐๐๐ง๐ง๐๐ฅ๐ฐ๐จ,
โพ๏ธ Syed Haider Shah, representing ๐๐๐ง๐ฌโs legal team.
โพ๏ธ The meeting was moderated by Katarzyna Barud, LL.M. Eur. (Munich).
We are proud that our partners at the Department of Innovation and Digitalisation in Law (University of Vienna) represented Phase4AI-EUProject, contributing valuable insights from our legal analysis of synthetic data in the context of healthcare regulation. Our participation highlighted key considerations for compliance, privacy, and the ethical use of synthetic data in AI systems.
Many thanks for the insightful discussion to both our panelists and the audience!
๐ More details on the event can be found here: https://lnkd.in/dejex-GW
